Creates a pure play Food Security company with pro forma revenue of approximately $1 billion and Adjusted EBITDA of approximately $300 million expected in its first full year post-closing. Pro forma company expected to have stronger growth through substantial cross synergies Combined company will have the enhanced geographic footprint, innovative product offerings, digitization capabilities, and […]
The partnership utilizes the highest-quality synthetic data in the market from Gretel to remove privacy bottlenecks and accelerate the development of precision medicine SAN DIEGO –Today, Gretel.ai announced a collaboration with Illumina, Inc. (NASDAQ: ILMN), the global leader in DNA sequencing and array-based technologies, to create privacy-protected, synthetic genomic data that can be accessed by medical researchers […]
Next-generation sequencing (NGS) enables a better understanding of genetic mechanisms linked to specific diseases and is helping drive personalised healthcare Preparing DNA for sequencing libraries is complex and prone to human error, which can interfere with accurate sequencing results The new AVENIO Edge System is a fully-automated solution for the sample preparation workflow, from DNA sample input […]
CARLSBAD, Calif. Overview: The Ion Torrent Oncomine Myeloid Assay GX v2* from Thermo Fisher Scientific is the first next-generation sequencing (NGS) assay that allows researchers to gather comprehensive mutational results from myeloid samples in a single day using the Ion Torrent Genexus System.* As the list of myeloid biomarkers continues to grow, rapid and streamlined solutions […]
TUCSON, Ariz. — HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, announced that it has exceeded $1 million of revenue recognized from sales of its HTG Transcriptome Panel (HTP) as of November 30, 2021. HTP was launched with commercial availability in the United […]
Study to assess the efficacy of blood-based comprehensive genomic profiling (CGP) in cancer therapy selection testing SAN DIEGO — Illumina, Inc. (NASDAQ:ILMN), today announced that it is supporting a national precision medicine study in Norway to assess the efficacy of blood-based comprehensive genomic profiling (CGP) in cancer therapy selection testing. The study will also evaluate […]
Oncomine Dx Target Test now approved for 12 NSCLC targeted therapies globally CARLSBAD, Calif. — The U.S. Food and Drug Administration (FDA) has granted premarket approval to Thermo Fisher Scientific‘s Oncomine Dx Target Test as a companion diagnostic (CDx) to help identify non-small cell lung cancer (NSCLC) patients whose tumors carry epidermal growth factor receptor (EGFR) Exon20-insertion mutations for potential […]
Maravai LifeSciences Foundation to support STEM, scientific education, community health, and COVID response SAN DIEGO — Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced it is establishing a new charitable foundation to promote causes tied to Maravai’s mission. The Maravai […]
SAN DIEGO — To signal that Cardea Bio, Inc. is investing significantly into the commercialization efforts of its brand new BPU™ (Biosignal Processing Unit) platform, Cardea is now unveiling a new logo, a new visual identity, a new website, and an updated focus on its core as a biocompatible semiconductor company, including establishing a new business unit […]
New NGS workflow accelerates the detection of SARS-CoV-2 variants including Omicron WALTHAM, Mass. — PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced the research use only (RUO) launch of the NEXTFLEX® Variant-Seq™ SARS-CoV-2 Kit v2 to accelerate the detection of SARS-CoV-2 variants. This complete next generation sequencing (NGS) solution will allow […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
